Hypertension health-tech firm Aktiia has announced a US$17.5 million Series A round of funding that will be used to accelerate its expansion in health systems across Europe.
Aktiia’s blood pressure monitoring system automatically measures blood pressure over the course of hours, days and weeks without any effort required by the wearer. The data is visualised in a free companion application, through which a digital summary can be easily shared with a physician or family member.
Aktiia says it already has tens of thousands of consumers across the UK, Ireland, Germany, Austria, France, Switzerland, and Italy. The Series A funding will be used to expand its offer to healthcare systems within these geographies as well as moving into new territories.
The brand is expanding its commercial footprint in key healthcare markets across Europe and the globe, starting with the appointment of new Head of European Healthcare Sales and Partnerships Richard Cardow, a twenty-year veteran of the cardiovascular monitoring industry.
“I believe we are only scratching the surface of the possible applications for the long-term 24/7 blood pressure data that Aktiia is uniquely capable of providing to physicians,” stated Melvin Lobo, NHS Professor of Cardiovascular Medicine and Director of St. Bartholomew’s Hospital Blood Pressure Clinic, London, UK. “This is an indisputable game changer in enabling a better understanding of our patients’ blood pressure patterns and how to treat them on a personalised basis.”
